相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。New and continuing developments at PROSITE
Christian J. A. Sigrist et al.
NUCLEIC ACIDS RESEARCH (2013)
Prediction of Cancer Incidence and Mortality in Korea, 2013
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2013)
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Hisao Nagoshi et al.
CANCER RESEARCH (2012)
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
Young Seok Ju et al.
GENOME RESEARCH (2012)
The transcriptional landscape and mutational profile of lung adenocarcinoma
Jeong-Sun Seo et al.
GENOME RESEARCH (2012)
Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
Joseph M. Gozgit et al.
MOLECULAR CANCER THERAPEUTICS (2012)
MET: a promising anticancer therapeutic target
Solange Peters et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
SMART 7: recent updates to the protein domain annotation resource
Ivica Letunic et al.
NUCLEIC ACIDS RESEARCH (2012)
Chimeric Transcript Generated by cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation
Yanmei Zhang et al.
CANCER DISCOVERY (2012)
Chromothripsis and cancer: causes and consequences of chromosome shattering
Josep V. Forment et al.
NATURE REVIEWS CANCER (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing
Zhi Jiang Zang et al.
CANCER RESEARCH (2011)
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
Dorothee Pflueger et al.
GENOME RESEARCH (2011)
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Dan R. Robinson et al.
NATURE MEDICINE (2011)
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing
Kalpana Kannan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD44-SLC1A2 Gene Fusions in Gastric Cancer
Jiong Tao et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Ted L. Underiner et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Fast and SNP-tolerant detection of complex variants and splicing in short reads
Thomas D. Wu et al.
BIOINFORMATICS (2010)
Integrative analysis of the melanoma transcriptome
Michael F. Berger et al.
GENOME RESEARCH (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Andrea Sboner et al.
GENOME BIOLOGY (2010)
Gene fusions and RNA trans-splicing in normal and neoplastic human cells
Hui Li et al.
CELL CYCLE (2009)
Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization
Norihiko Kawamata et al.
LEUKEMIA RESEARCH (2009)
The identification of microRNAs in a genomically unstable region of human chromosome 8q24
Konrad Huppi et al.
MOLECULAR CANCER RESEARCH (2008)
A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells
Hui Li et al.
SCIENCE (2008)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
GA Smolen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Drug therapy: Imatinib mesylate - A new oral targeted therapy.
DG Savage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)